As of 2026, the AI cancer diagnostics market is valued at approximately $1.28 billion, and it is expected to double by 2035 (Towards Healthcare, 2026).
A biologist widely recognized for his groundbreaking contributions to genomics, including leading efforts to sequence the first draft of the human genome, Venter and his team’s successful creation of the first synthetic bacterial cell is considered pivotal to the field of synthetic biology.
The twenty-first century has ushered in an era of unprecedented technological advancements, transforming virtually every aspect of human life. From health sciences to social...